Abstract:ABSTRACT Bacterial growth and metabolic rates are often closely related. However, under antibiotic selection, a paradox in this relationship arises: antibiotic efficacy decreases when bacteria are metabolically dormant, yet antibiotics select for resistant cells that grow fastest during treatment. That is, antibiotic selection counterintuitively favors bacteria with fast growth but slow metabolism. Despite this apparent contradiction, antibiotic resistant cells have historically been characterized primarily in the context of growth, whereas the extent of analogous changes in metabolism is comparatively unknown. Here, we observed that previously evolved antibiotic-resistant strains exhibited a unique relationship between growth and metabolism whereby nutrient utilization became more efficient, regardless of the growth rate. To better understand this unexpected phenomenon, we used a simplified model to simulate bacterial populations adapting to sub-inhibitory antibiotic selection through successive bottlenecking events. Simulations predicted that sub-inhibitory bactericidal antibiotic concentrations could select for enhanced metabolic efficiency, defined based on nutrient utilization: drug-adapted cells are able to achieve the same biomass while utilizing less substrate, even in the absence of treatment. Moreover, simulations predicted that restoring metabolic efficiency would re-sensitize resistant bacteria exhibiting metabolic-dependent resistance; we confirmed this result using adaptive laboratory evolutions of Escherichia coli under carbenicillin treatment. Overall, these results indicate that metabolic efficiency is under direct selective pressure during antibiotic treatment and that differences in evolutionary context may determine both the efficacy of different antibiotics and corresponding re-sensitization approaches. IMPORTANCE The sustained emergence of antibiotic-resistant pathogens combined with the stalled drug discovery pipelines highlights the critical need to better understand the underlying evolution mechanisms of antibiotic resistance. To this end, bacterial growth and metabolic rates are often closely related, and resistant cells have historically been characterized exclusively in the context of growth. However, under antibiotic selection, antibiotics counterintuitively favor cells with fast growth, and slow metabolism. Through an integrated approach of mathematical modeling and experiments, this study thereby addresses the significant knowledge gap of whether antibiotic selection drives changes in metabolism that complement, and/or act independently, of antibiotic resistance phenotypes.

Adenosine Awakens Metabolism to Enhance Growth-Independent Killing of Tolerant and Persister Bacteria across Multiple Classes of Antibiotics

Adenosine Monophosphate as a Metabolic Adjuvant Enhances Antibiotic Efficacy against Drug-Resistant Bacterial Pathogens

Eradication of bacterial persister cells by leveraging their low metabolic activity using adenosine triphosphate coated gold nanoclusters

Bacteria primed by antimicrobial peptides develop tolerance and persist

Unlocking the enigma of phenotypic drug tolerance: Mechanisms and emerging therapeutic strategies

Antibiotic tolerance among clinical isolates: mechanisms, detection, prevalence, and significance

Antibiotic resistance and tolerance: What can drug delivery do against this global threat?

Sub-inhibitory antibiotic treatment selects for enhanced metabolic efficiency

Antimicrobial Peptides can Generate Tolerance by Lag and Interfere with Antimicrobial Therapy

Dynamic protein aggregation regulates bacterial dormancy depth critical for antibiotic tolerance

Enhanced Efflux Activity Facilitates Drug Tolerance in Dormant Bacterial Cells

Metabolic conservation by protein quality control in underlies the antibiotic tolerance

Influence of Bacterial Metabolism on Antibiotic Resistance and Its Enlightenment for the R&D of Antibacterial Drugs

Rethinking Dormancy: Antibiotic Persisters are Metabolically Active, Non-Growing Cells

Potentiating aminoglycoside antibiotics to reduce their toxic side effects

Proton motive force and antibiotic tolerance in bacteria

Microbial environments confound antibiotic efficacy

Identification of a Small Molecule Compound Active against Antibiotic-Tolerant Staphylococcus aureus by Boosting ATP Synthesis

Preserving the efficacy of antibiotics to tackle antibiotic resistance

Pleiotropic cellular responses underlying antibiotic tolerance in

Effect of Tolerance on the Evolution of Antibiotic Resistance under Drug Combinations